Repositorio Institucional de la Universidad de Oviedo

Mostrando ítems 1-4 de 4

SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation

Redin, E.; Garmendia, I.; Lozano, T.; Serrano, D.; Senent, Y.; Redrado, M.; Villalba, M.; De Andrea, C. E.; Exposito, F.; Ajona, D.; Ortiz Espinosa, S.; Remirez, A.; Bertolo, C.; Sainz, C.; García Pedrero, Juana María (2021)
The differential impact of SRC expression on the prognosis of patients with head and neck squamous cell carcinoma

Hermida Prado, Francisco José; Granda Díaz, Rocío; Río Ibisate, Nagore del; Villaronga Torres, María de los Ángeles; Allonca Campa, Eva; Garmendia, I.; Montuenga, L. M.; Rodríguez González, René; Vallina Álvarez, Aitana; Álvarez Marcos, César Antonio; Rodrigo Tapia, Juan Pablo; García Pedrero, Juana María (2019)
Tumor-intrinsic nuclear β-catenin associates with an immune ignorance phenotype and a poorer prognosis in head and neck squamous cell carcinomas

Sánchez Canteli, Mario; Juesas, L.; Garmendia, I.; Otero Rosales, M.; Calvo, A.; Álvarez Fernández, M.; Astudillo González, María Aurora; Montuenga, L. M.; García Pedrero, Juana María; Rodrigo Tapia, Juan Pablo (2022)
YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib

Garmendia, I.; Pajares, M. J.; Hermida Prado, Francisco José; Ajona, D.; Rodrigo Tapia, Juan Pablo; García Pedrero, Juana María (2019)